title: [Aorto-iliac reconstruction after kidney transplantation with in situ transplant perfusion with HTK solution].
abstract: A case report of a 57 year old male is presented, who underwent kidney transplantation in 1987. Subsequently he developed arterial occlusive disease. A bifurcated prosthesis was implanted and the graft preserved by in-situ-perfusion with HTK-solution (Custodiol). The graft artery was anastomosed in an end to side fashion to the prosthesis. The postoperative course was uncomplicated with unimpaired renal function. We conclude that in-situ-perfusion with cold HTK-solution represents a simple method for kidney graft protection during reconstructive vascular procedures.
authors.affiliation: Abteilung für Thorax-, Herz- und Gefässchirurgie, Medizinische Hochschule Hannover.
authors.forename: U
authors.initials: U
authors.lastname: Franke
authors.forename: T
authors.initials: T
authors.lastname: Wahlers
authors.forename: S
authors.initials: S
authors.lastname: Raygrotzky
authors.forename: H G
authors.initials: HG
authors.lastname: Fieguth
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
mesh_terms: D001012:Aorta, Abdominal / Q000601:surgery*; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007083:Iliac Artery / Q000601:surgery*; D007383:Intermittent Claudication / Q000601:surgery*; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000000981:diagnostic imaging / Q000379:methods*; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D008875:Middle Aged; D009926:Organ Preservation / Q000379:methods*; D010477:Perfusion / Q000379:methods*; D011183:Postoperative Complications / Q000601:surgery*; D011189:Potassium Chloride / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D011859:Radiography; D012086:Reoperation
chemical_list: C039984:Bretschneider cardioplegic solution; D008353:Mannitol; D011343:Procaine; D011189:Potassium Chloride; D005947:Glucose
vernacular_title: Die aortoiliakale Rekonstruktion nach Nierentransplantation unter In-situ-Transplantatperfusion mit HTK-Lösung.